Non-Current Assets
Equity securities
Medtronic Equity securities decreased by 12.3% to $50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 83.9%, from $311M to $50M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2024
Last reportedQ3 2026Feb 24, 2026
Metric ID:
ins_equity_securitiesHistorical Data
8 periods
| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $311M | $311M | $311M | $311M | $140M | $50M | $57M | $50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -55.0% | -64.3% | +14.0% | -12.3% |
| YoY Change | — | — | — | — | -55.0% | -83.9% | -81.7% | -83.9% |
Range$50M – $311M
CAGR-64.8%
Avg YoY Growth-76.1%
Median YoY Growth-82.8%
Equity securities at Other Companies
Frequently Asked Questions
- What is Medtronic's equity securities?
- Medtronic (MDT) reported equity securities of $50M in Q4 2025.
- How has Medtronic's equity securities changed year-over-year?
- Medtronic's equity securities decreased by 83.9% year-over-year, from $311M to $50M.